Himalaya-The podcast Player

4.8K Ratings
Open in app
title

Best Science Medicine Podcast - BS without the BS

Dr James McCormack and Dr Michael Allan

60
Followers
43
Plays
Best Science Medicine Podcast - BS without the BS

Best Science Medicine Podcast - BS without the BS

Dr James McCormack and Dr Michael Allan

60
Followers
43
Plays
OVERVIEWEPISODESYOU MAY ALSO LIKE

Details

About Us

The Best Science (BS) Medicine Podcast is a weekly presentation where practitioners can get evidence-based drug therapy content that is practical, entertaining and promotes healthy scepticism. In essence, we are the Medication Mythbusters. We present information that is useful and relevant to physicians, pharmacists, nurses, physician assistants and other health professionals, and that can easily be incorporated into day-to-day practice. The podcast is presented by Dr. James McCormack, Professor in the Faculty of Pharmaceutical Sciences at the University of British Columbia and Dr Michael Allan, Associate Professor in the Department of Family Practice at the University of Alberta. For more about us and to get the show notes for each episode, visit our website at www.bsmedicine.com or www.medicationmythbusters.com

Latest Episodes

Episode 448: Unmasking the evidence around masks for healthcare workers

In episode 448, Mike and James go over all the evidence around masks for preventing viral respiratory infections in healthcare workers. We find that surgical masks and N95 masks provide similar protection against viral infections. Unfortunately we have no evidence for COVID-19. Show notes Tools for Practice

-1 s3 w ago
Comments
Episode 448: Unmasking the evidence around masks for healthcare workers

Episode 447: Stealth style transmission? Covert data on COVID-19

In episode 447, Mike and James invite Tina and Mike to talk about a really important topic – is there asymptomatic transmission of COVID-19? The simple answer is yes. Have a listen and hear about all the data and the numbers. Show notes Tools for Practice

21 MINAPR 17
Comments
Episode 447: Stealth style transmission? Covert data on COVID-19

Episode 446: COVID -19 A rushed introduction to an uninvited guest

In episode 446, Mike and James invite Mike and Tina to talk about all things COVID. In this podcast we look at what are the presenting symptoms, the clinical course and the risk factors for mortality. Show notes Tools for Practice

27 MINAPR 16
Comments
Episode 446: COVID -19 A rushed introduction to an uninvited guest

Episode 445: COVID and breathlessness - are there any objective tools to assess breathlessness over the phone?

In episode 445, Mike and James wade into the evidence-free zone (pretty much) around assessing dyspnea over a telephone/video conference. We talk about the Roth score, respiratory rate, fever, and patient self-rating of dyspnea. Have a listen and see what we found. Show notes The BMJ

29 MINAPR 9
Comments
Episode 445: COVID and breathlessness - are there any objective tools to assess breathlessness over the phone?

Episode 444: Hydroxychloroquine with or without azithromycin for COVID-19

In episode 444, James and Mike wade into the evidence quagmire around hydroxychloroquine and COVID-19. The bottom line is the evidence will likely be different around the time you listen to the podcast. So listen quickly. Show notes 1)Tools for Practice

30 MINAPR 1
Comments
Episode 444: Hydroxychloroquine with or without azithromycin for COVID-19

Episode 443: Electronic Cigarettes - Hoot that helps, hurts, or just hype?

In episode 443, James and Mike continue with Mike Kolber and we discuss the evidence around electronic cigarettes and their use for smoking cessation. Overall, the podcast ends up being smoking hot in so many ways. Show notes Tools for Practice

20 MINMAR 27
Comments
Episode 443: Electronic Cigarettes - Hoot that helps, hurts, or just hype?

Episode 442: Are biosimilars similar to biologics for inflammatory conditions?

In episode 442, James and Mike welcome back Mike Kolber to discuss all the evidence around biosimilars. The issue is exactly the same one we have had for decades with the question around brand name versus generic medications. Tune in and find out the answer. Show notes Tools for Practice

-1 sMAR 17
Comments
Episode 442: Are biosimilars similar to biologics for inflammatory conditions?

Episode 441: Guidelines could be so much better, but here is why they aren’t, yet

In episode 441, James and Mike revisit the problem with guidelines. We talk about recent writings on the issues around guidelines. We discuss the main problems and believe it or not we give advice and suggestions for how to make them better. Show notes 1) Health Affair

-1 sMAR 10
Comments
Episode 441: Guidelines could be so much better, but here is why they aren’t, yet

Episode 440: Putting the FUN in Fungi: Toenail onychomycosis treatments

In episode 440, Mike and James yet again invite Adrienne to go over all the evidence for treating toenail onychomycosis. We find that ~ 40% more people get better on oral treatments than on placebo. For topicals the number is closer to 10%. Topicals should likely only be used if there is <40% nail involvement. Show notes Tools For Practice

28 MINFEB 28
Comments
Episode 440: Putting the FUN in Fungi: Toenail onychomycosis treatments

Episode 439: Taking a hard look at the evidence: PDE5 inhibitors in erectile dysfunction

In episode 439, Mike and James invite Adrienne to take us through the impressively large amount of evidence for the PDE5 inhibitors for erectile dysfunction. We find that the NNTs are 2-3 for the not clearly defined endpoint of successful intercourse. There is a 20% absolute increase in adverse effects but almost no one stops using these medications because of these effects. Go figure.

24 MINFEB 11
Comments
Episode 439: Taking a hard look at the evidence: PDE5 inhibitors in erectile dysfunction
the END

Latest Episodes

Episode 448: Unmasking the evidence around masks for healthcare workers

In episode 448, Mike and James go over all the evidence around masks for preventing viral respiratory infections in healthcare workers. We find that surgical masks and N95 masks provide similar protection against viral infections. Unfortunately we have no evidence for COVID-19. Show notes Tools for Practice

-1 s3 w ago
Comments
Episode 448: Unmasking the evidence around masks for healthcare workers

Episode 447: Stealth style transmission? Covert data on COVID-19

In episode 447, Mike and James invite Tina and Mike to talk about a really important topic – is there asymptomatic transmission of COVID-19? The simple answer is yes. Have a listen and hear about all the data and the numbers. Show notes Tools for Practice

21 MINAPR 17
Comments
Episode 447: Stealth style transmission? Covert data on COVID-19

Episode 446: COVID -19 A rushed introduction to an uninvited guest

In episode 446, Mike and James invite Mike and Tina to talk about all things COVID. In this podcast we look at what are the presenting symptoms, the clinical course and the risk factors for mortality. Show notes Tools for Practice

27 MINAPR 16
Comments
Episode 446: COVID -19 A rushed introduction to an uninvited guest

Episode 445: COVID and breathlessness - are there any objective tools to assess breathlessness over the phone?

In episode 445, Mike and James wade into the evidence-free zone (pretty much) around assessing dyspnea over a telephone/video conference. We talk about the Roth score, respiratory rate, fever, and patient self-rating of dyspnea. Have a listen and see what we found. Show notes The BMJ

29 MINAPR 9
Comments
Episode 445: COVID and breathlessness - are there any objective tools to assess breathlessness over the phone?

Episode 444: Hydroxychloroquine with or without azithromycin for COVID-19

In episode 444, James and Mike wade into the evidence quagmire around hydroxychloroquine and COVID-19. The bottom line is the evidence will likely be different around the time you listen to the podcast. So listen quickly. Show notes 1)Tools for Practice

30 MINAPR 1
Comments
Episode 444: Hydroxychloroquine with or without azithromycin for COVID-19

Episode 443: Electronic Cigarettes - Hoot that helps, hurts, or just hype?

In episode 443, James and Mike continue with Mike Kolber and we discuss the evidence around electronic cigarettes and their use for smoking cessation. Overall, the podcast ends up being smoking hot in so many ways. Show notes Tools for Practice

20 MINMAR 27
Comments
Episode 443: Electronic Cigarettes - Hoot that helps, hurts, or just hype?

Episode 442: Are biosimilars similar to biologics for inflammatory conditions?

In episode 442, James and Mike welcome back Mike Kolber to discuss all the evidence around biosimilars. The issue is exactly the same one we have had for decades with the question around brand name versus generic medications. Tune in and find out the answer. Show notes Tools for Practice

-1 sMAR 17
Comments
Episode 442: Are biosimilars similar to biologics for inflammatory conditions?

Episode 441: Guidelines could be so much better, but here is why they aren’t, yet

In episode 441, James and Mike revisit the problem with guidelines. We talk about recent writings on the issues around guidelines. We discuss the main problems and believe it or not we give advice and suggestions for how to make them better. Show notes 1) Health Affair

-1 sMAR 10
Comments
Episode 441: Guidelines could be so much better, but here is why they aren’t, yet

Episode 440: Putting the FUN in Fungi: Toenail onychomycosis treatments

In episode 440, Mike and James yet again invite Adrienne to go over all the evidence for treating toenail onychomycosis. We find that ~ 40% more people get better on oral treatments than on placebo. For topicals the number is closer to 10%. Topicals should likely only be used if there is <40% nail involvement. Show notes Tools For Practice

28 MINFEB 28
Comments
Episode 440: Putting the FUN in Fungi: Toenail onychomycosis treatments

Episode 439: Taking a hard look at the evidence: PDE5 inhibitors in erectile dysfunction

In episode 439, Mike and James invite Adrienne to take us through the impressively large amount of evidence for the PDE5 inhibitors for erectile dysfunction. We find that the NNTs are 2-3 for the not clearly defined endpoint of successful intercourse. There is a 20% absolute increase in adverse effects but almost no one stops using these medications because of these effects. Go figure.

24 MINFEB 11
Comments
Episode 439: Taking a hard look at the evidence: PDE5 inhibitors in erectile dysfunction
the END
hmly
Welcome to Himalaya Premium